Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    melanoma | Open Studies | interleukin-2
Show Display Options
Rank Status Study
21 Recruiting Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Biological: Therapeutic Tumor Infiltrating Lymphocytes
22 Recruiting Interleukin-2—Induced Cognitive/Affective/Sleep Symptoms
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Melanoma;   High-dose Interleukin-2
Intervention:
23 Recruiting Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.
Conditions: Malignant Melanoma;   Adjuvant Drug Therapy;   Vaccin Therapy
Intervention: Biological: Autologous Dendritic Cell vaccine
24 Recruiting Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy
Condition: Metastatic Melanoma
Intervention: Biological: tumor infiltrating lymphocytes
25 Recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Young TIL
26 Recruiting A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma
Condition: Metastatic Melanoma Stage IV
Interventions: Drug: Arm 1: L19IL2 + Dacarbazine;   Drug: Arm 2: Dacarbazine
27 Recruiting Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients
Conditions: Solid Tumour,;   Breast Cancer,;   Metastatic Melanoma,;   Non-small Cell Lung Cancer (NSCLC),
Intervention: Drug: F16IL2 in combination with paclitaxel
28 Recruiting TIL Therapy for Metastatic Ovarian Cancer
Condition: Metastatic Ovarian Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: TIL infusion;   Drug: Interleukin-2
29 Recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Conditions: Metastatic Colorectal Cancer;   Metastatic Gastric Cancer;   Metastatic Pancreatic Cancer;   Metastatic Hepatocellular Carcinoma;   Metastatic Cholangiocarcinoma
Interventions: Biological: Young TIL;   Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Pembrolizumab
30 Recruiting Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans
Condition: Cancer
Intervention: Biological: Bromelain and Comosain

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years